A study by researchers from University Hospital in Basel, Switzerland has revealed that patients with relapsing-remitting multiple sclerosis (MS) may benefit from early and long-term treatment with interferon beta-1a. Furthermore, the MRI scans of the patients undergoing the therapy showed a delay in long-term disease progression.

Multiple sclerosis is an autoimmune disease, which occurs when the body's defense system starts attacking a crucial proteinacious layer on the nerves, resulting in serious movement problems and other symptoms. Relapsing-remitting MS, is the initial form of the disease, in which MS attacks are separated by periods of relatively normal function

Recent research shows that pregnant women should be careful about keeping a healthy diet since its essential in giving birth to healthy babies; reports show that infants with low birth weight could have cognitive and physical problems by the time they are adolescents.

The report is included in the October 2006 issue of Archives of Pediatrics & Adolescent Medicine and states that 16-year olds born with a weight of less than 4.5 pounds (not disabled) have more of a chance of developing physical and mental difficulties than the average teenager

A research study recommends talking and exercise therapy for those with chronic fatigue syndrome (CFS).

CFS gave the best response to those therapies with drug treatments having no benefit

A study proposes that vitamin shots may avert severe long-term disability in multiple sclerosis patients. Presently there is no adequate treatment for the chronic progressive phase of MS.

The study results showed that there was a decrease in nerve degeneration in mice with MS-type symptoms when they were given a form of vitamin B3 called nicotinamide

A study finds that vitamin shots may prevent long-term disability in multiple sclerosis patients.

Scientists have not yet found an effective treatment for the chronic progressive state of MS, when serious disability most commonly occurs.

In the Children's Hospital Boston study, researchers gave mice a form of vitamin B3 called nicotinamide. This treatment reduced the risk of nerve degeneration in mice with MS-like symptoms